CALGB A Randomized Double-Blinded Phase III Study Comparing Gemcitabine; Cisplatin; and Bevacizumab to Gemcitabine; Cisplatin; and Placebo in Patients with Advanced Transitional Cell Carcinoma Adult CIRB - Late Phase Emphasis Closed to Accrual. Pts Still Rcving Intervention Completed